[ Price : $8.95]
FDA says it is evaluating preliminary data from a clinical trial showing an increased overall risk of death for patients on dual a...[ Price : $8.95]
FDA approves a Genzyme NDA for Lemtrada (alemtuzumab) for treating patients with relapsing forms of multiple sclerosis.[ Price : $8.95]
Solgar, Inc. recalls its ABC Dophilus Powder after testing by the Centers for Disease Control revealed the presence of Rhizopus or...[ Price : $8.95]
FDA says an ongoing hold on China-issued visas is expected to be lifted in the coming weeks which will double its inspectional pre...[ Price : $8.95]
An ongoing CDRH customer survey finds that 84% of respondents are satisfied with the Centers customer service.[ Price : $8.95]
A new report from FDA to Congress says the agency is concerned that too many petitions continue to be submitted as a strategy to d...[ Price : $8.95]
Federal Register Notice: FDA releases a draft guidance: Rare Pediatric Disease Priority Review Vouchers.[ Price : $8.95]
Federal Register Notice: FDA withdraws approval of 14 NDAs from multiple application holders due to a failure to file annual repor...